JSR Life Sciences logo Newsroom
Search in newsroom
Receive exclusive news
English
Search in newsroom
jsrlifesciences.com

What are you looking for?

Latest news

Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation

Indivumed Services GmbH, a Crown Bioscience company, has received laboratory accreditation from the College of American Pathologists (CAP), highlighting its commitment to excellence in laboratory s...

Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

Crown Bioscience collaborates with HanX Biopharmaceutical, enabling the progression of HX009 to clinical trials for the treatment of lymphoma. The study demonstrates the efficacy of HX009 in target...

KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO.

New Antibody Development for Use in Drug Delivery to Motor Nerves

MBL raised and delivered monoclonal antibodies for Jiksak Bioengineering, a startup company with proprietary technologies developed for new therapeutic innovation in motor neuron degenerative disea...

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical ...

Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes

JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organiz...

KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and M...

KBI Biopharma, Inc. (KBI Biopharma), a JSR Life Sciences company, today announced the launch of SUREmAb™, an offering built on the robustness of KBI’s SUREtechnology Platform, that allows for optim...

Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation

Indivumed Services GmbH, a Crown Bioscience company, has received laboratory accreditation from the College of American Pathologists (CAP), highlighting its commitment to excellence in laboratory s...

Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

Crown Bioscience collaborates with HanX Biopharmaceutical, enabling the progression of HX009 to clinical trials for the treatment of lymphoma. The study demonstrates the efficacy of HX009 in target...

KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO.

New Antibody Development for Use in Drug Delivery to Motor Nerves

MBL raised and delivered monoclonal antibodies for Jiksak Bioengineering, a startup company with proprietary technologies developed for new therapeutic innovation in motor neuron degenerative disea...

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical ...

Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes

Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation

Indivumed Services GmbH, a Crown Bioscience company, has received laboratory accreditation from the College of American Pathologists (CAP), highlighting its commitment to excellence in laboratory s...

Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

Crown Bioscience collaborates with HanX Biopharmaceutical, enabling the progression of HX009 to clinical trials for the treatment of lymphoma. The study demonstrates the efficacy of HX009 in target...

Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank

Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, announced today that it has completed its acquisition of the IndivuServ business unit of Indivumed Gmb...

Crown Bioscience opens Singapore Laboratory and Establishes Local Commercial Partner

The new facility expands the company’s capacity to support both global and local biotech and pharma companies engaged in preclinical and translational oncology drug discovery and development.

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank

Acquisition expands global service offering to include access and analysis of unique clinical biospecimens

Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived ...

Crown Bioscience announced today their newly published study in PLOS ONE demonstrating the establishment and application of a clinically relevant 3D in vitro PDX-derived organoid biobank for higher...

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and M...

KBI Biopharma, Inc. (KBI Biopharma), a JSR Life Sciences company, today announced the launch of SUREmAb™, an offering built on the robustness of KBI’s SUREtechnology Platform, that allows for optim...

KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO.

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical ...

Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes

JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organiz...

KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers

KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific O...

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the appointment of Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer. The ...

KBI Biopharma Appoints David Stewart as Site Head of Durham Mammalian cGMP Manufacturing Facility

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the appointment of David Stewart as the new SVP and Site Head of KBI’s mammalian cGMP manufacturing facility in Durham, North...

New Antibody Development for Use in Drug Delivery to Motor Nerves

MBL raised and delivered monoclonal antibodies for Jiksak Bioengineering, a startup company with proprietary technologies developed for new therapeutic innovation in motor neuron degenerative disea...

MBL Obtains Regulatory Approval for SARS-CoV-2 and Influenza Virus Antigen Test OTC Kit

This product detects the SARS-CoV-2 and Influenza virus antigen in nasal swab fluid by the immunochromatography method. MBL can sell this product at pharmacies, drugstores and pharmacy online sites.

MBL Launches an OTC Kit for SARS-CoV-2 Antigen Test

Medical & Biological Laboratories Co., Ltd. successfully acquired regulatory approval on November 11, 2022 for its SARS-CoV-2 antigen test OTC kit “GLINE-2019-nCoV Agキット（一般用).”

Crown Bioscience & MBL Launch Joint Venture to Serve Japanese Biopharmaceutical Community

Crown Bioscience & MBL, a joint venture between two JSR Life Sciences companies formed earlier this year, announce today the launch of their full-service drug discovery and development capabilities...

MBL Launches a Kit for Simultaneous Detection of SARS-CoV-2 and Influenza Virus Antigens

This kit detects the SARS-CoV-2 antigen, influenza A virus antigen, and influenza B virus antigen in nasopharyngeal or nasal swab fluid using an immunochromatographic method.

MBL Obtained European Quality Management System Certificate (IVDR)

The certification ensures that the CE marked diagnostic products supplied by MBL adhere to standards of quality and safety that ensure the highest level of patients’ health protection

JSR Begins Development of Raw Materials from Biomass

Through joint development with Bacchus Bio innovation, JSR will develop and produce raw materials for its key biomass products utilizing synthetic biology.　

Ajinomoto Co., Inc. and JSR Corporation Agree to Collaborate in Development of Global Biopharmaceutical Culture Media...

Ajinomoto Co. has reached an agreement with JSR to collaborate on the global expansion of its biopharmaceutical culture media business, adding new high-performance media developed by JSR, to Ajinom...

JSR Invites AuB Co., Ltd. to Kawasaki Collaborative Research Facility, JSR BiRD, Challenging Value Creation in the Mi...

JSR Corporation announced today that it has entered into a facility usage agreement with AuB, a company engaged in the study of intestinal microbiota in athletes.

JSR, the collaborative research facility "JSR BiRD" in Kawasaki, invites KINS Co., Ltd.

JSR Corporation announced today that it has concluded a facility use agreement with KINS Co., Ltd. (KINS), a company with a database of human microbiome.

JSR and Asahi Kasei Medical Enter Co-promotion Agreement

JSR Life Sciences, LLC is pleased to announce that JSR Corporation and Asahi Kasei Medical have entered into a co-promotion agreement for bioprocess products and materials that initiated sales coll...

Upcoming events

Festival of Biologics 2023
Basel, Switzerland
Learn more
BioJapan
Pacifico, Yokohama, Japan
Learn more
The 10th Annual meeting of Japanese society for Extracellular vesicles
Hokkaido University, Japan
Learn more

News topics

img-description

JSR Life Sciences

JSR Life Sciences is committed to the advancement of human health worldwide as a strategic partner to companies that discover, develop & deliver products to treat disease & improve quality of life

img-description

Crown Bioscience

Crown Bioscience is a global CRO providing preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases

img-description

KBI Biopharma

KBI Biopharma is an award winning CDMO providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical & biotechnology companies globally

img-description

MBL

MBL is committed to being a leading manufacturer & supplier of diagnostic reagents that facilitate further advances in personalized medicine & individualization of medical care

img-description

JSR Corporation

JSR Corporation's mission is to contribute to social good by supplying materials to serve future generations & providing new value today for their customers & society

Receive exclusive news

Are you a journalist or do you work for a publication?
Sign up and request access to exclusive news.

Request access

Receive JSR Life Sciences news on your RSS reader.

Subscribe with RSS
Or subscribe through Atom URL manually
Search the entire JSR Life Sciences Newsroom

Find news releases, media kits and clippings

Navigate to a media section